AtriCure (ATRC) vs Azenta (AZTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
AtriCure (ATRC) has outperformed Azenta (AZTA) over the past year, gaining 56.2% versus a gain of 16.8%. Over five years, ATRC leads with a -25.3% price change compared with -65.3% for AZTA. AtriCure is the larger company by market cap ($2.71 billion vs $1.57 billion), about 1.7 times the size.
On valuation, Azenta trades at a lower forward P/E (65.0x vs 122.8x for AtriCure).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATRC | AZTA |
|---|---|---|
| Share price | $53.31 | $35.89 |
| Market cap | $2.71B | $1.57B |
| 1-day change | -0.69% | -8.79% |
| YTD return | +34.76% | +7.91% |
| 1-year return | +56.24% | +16.79% |
| 5-year return | -25.30% | -65.31% |
| P/E ratio (TTM) | 253.86 | — |
| Forward P/E | 122.84 | 64.96 |
| EPS (TTM) | $0.21 | $-2.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $61.70 | $46.41 |
| 52-week low | $25.36 | $15.93 |
| Distance from 52-week high | -13.60% | -22.67% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +2.96% | +3.09% |
| Average volume | 1.09M | 848.18K |
| Shares outstanding | 50.87M | 43.81M |
| Employees | 1,350 | 2,900 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ATRC has outperformed AZTA by 39.5 percentage points over the past year.
About AtriCure
ATRC stock →AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.
Healthcare · Medical Instruments & Supplies · 1,350 employees
About Azenta
AZTA stock →Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
Healthcare · Medical Instruments & Supplies · 2,900 employees
ATRC vs AZTA FAQ
Which is bigger, AtriCure or Azenta?
AtriCure (ATRC) is larger, with a market capitalization of $2.71B compared with $1.57B for Azenta (AZTA).
Which stock has performed better over the past year, ATRC or AZTA?
ATRC returned +56.24% over the past 12 months, compared with +16.79% for AZTA (price return, excluding dividends). Past performance does not predict future results.
Are AtriCure and Azenta in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.